CLINICAL_TRIALS
trial_result
· 2024-11-14
Clinical Trial Update: Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices [Phase 2]
Summary
Phase 2 trial assessing the hemocompatibility of apixaban in patients with left ventricular assist devices has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Palak Shah | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2024-11-14